Adult-Onset MELAS Presenting as Herpes Encephalitis
Arch Neurol 56:241-243, Sharfstein,S.R.,et al, 1999
Migraine and Stroke in Young Women:Case-Control Study
BMJ 318:13-18, Chang,C.L.,et al, 1999
Fatal Guillain-Barre Syndrome
Neurol 52:635-638, Lawn,N.D.&Wijdicks,E.F.M., 1999
Surgical Treatment and Risk of Sporadic Creutzfeldt-Jakob Disease:A Case-Control Study
Lancet 353:693-697, Collins,S.,et al, 1999
Course and Treatment of Myasthenia Gravis During Pregnancy
Neurol 52:447-452, Batocchi,A.P.,et al, 1999
Cerebral Polyopia with Extrastriate Quadrantanopia:Report of a Case with Magnetic Resonance Documentation of V2/V3 Cortical Infarction
J Neuro-Ophthalmol 19:1-6, Jones,M.R.,et al, 1999
Diagnostic Criteria for Parkinson Disease
Arch Neurol 56:33-39, Gelb,D.J.,et al, 1999
Clinical Correlates of Vascular Parkinsonism
Arch Neurol 56:98-102, Winikates,J.&Jancovic,J., 1999
Long-Term Evaluation of Bilateral Fetal Nigral Transplantation in Parkinson Disease
Arch Neurol 56:179-187, Hauser,R.A.,et al, 1999
Spastic Paraparesis after Anaesthesia
Lancet 353:554, Lee,P.,et al, 1999
Early Prognostic Indicators of Outcome in Infants with Neonatal Cerebral Infarction:A Clinical,Electroencephalogram,and Magnetic Resonance Imaging Study
Pediatrics 103:39-46, Mercuri,E.,et al, 1999
Arteriovenous Malformations of the Brain in Adults
NEJM 340:1812-1818, The Arteriovenous Malformation Study Group, 1999
Intravenous Heparin for Acute Stroke, What Can We Learn from the Megatrials?
Neurol 52:1746-1750, Swanson,R.A., 1999
Factors Associated with Ischemic Stroke During Aspirin Therapy in Atrial Fibrillation, Analysis of 2012 Participants in the SPAF-I-III Clinical Trials
Stroke 30:1223-1229, Hart,R.G.,et al, 1999
Risk Assessment and Anticoagulation for Primary Stroke Prevention in Atrial Fibrillation
Stroke 30:1218-1222, Kalra,L.,et al, 1999
Which Unruptured Cerebral Aneurysms Should be Treated? A Cost-Utility Analysis
Neurol 52:1806-1815, Johnston,S.C.,et al, 1999
Risk of Subarachnoid Hemorrhage After Surgical Treatment of Unruptured Cerebral Aneurysms
Stroke 30:1181-1184, Tsutsumi,K.,et al, 1999
Surgical and Endovascular Treatment of Unruptured Cerebral Aneurysms at University Hospitals
Neurol 52:1799-1805, Johnston,S.C.,et al, 1999
Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year
NEJM 340:1781-1787, Kwiatkowski,T.G.,et al, 1999
Progression of Mass Effect After Intracerebral Hemorrhage
Stroke 30:1167-1173, Zazulia,A.R.,et al, 1999
Multiple large and Small Cerebellar Infarcts
JNNP 66:739-745, Sanaple,S.&Bogousslavsky,J., 1999
Rapid Ambulance Protocol for Acute Stroke
Lancet 353:1935, Harbison,J.,et al, 1999
Lack of Evidence of an Association Between Mitral-Valve Prolapse and Stroke in Young Patients
NEJM 341:8-13,48, Gilon,D.,et al, 1999
Pontine Anosognosia for Hemiplegia
Neurol 53:647-649, Evyapan,D.&Kumral,E., 1999
An Uncommon Cause of Stroke in Young Adults
Arch Neurol 56:1018-1020, vanPutten,M.J.A.M.,et al, 1999
Therapeutic Benefit, Aspirin Revisited in Light of the Introduction of Clopidogrel
Stroke 30:1716-1721, Gorelick,P.B.,et al, 1999
Prethrombotic Disorders in Children with Arterial Ischemic Stroke and Sinovenous Thrombosis
Arch Neurol 56:967-971, Bonduel,M.,et al, 1999
Intraarterial Thrombolysis for Treatment of Acute Stroke:Experience in 26 Patients with Long-Term Follow-Up
AJNR 20:1291-1299, 1194, Jahan,R.,et al, 1999
Homocyst(e)ine and Risk of Cerebral Infarcdtion in a Biracial Population, The Stroke Prevention in Young Women Study
Stroke 30:1554-1560, Kittner,S.J.,et al, 1999
Demyelinative Brainstem Encephalitis Responsive to Intravenous Immunoglobulin Therapy
Pediatrics 104:301-304, Assa,A.,et al, 1999
Chronic Thalamic Stimulation for the Tremor of Multiple Sclerosis
Neurol 53:625-628, Montgomery,E.B.,et al, 1999
A Sneezer's Headache
Neurol 53:654-655, Kurita,H.,et al, 1999
Intravenous Immunoglobulin Treatment in Neurologic Disorders
Arch Neurol 56:1025-1027,1032, Sorensen,P.S., 1999
Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?
Arch Neurol 56:1028-1032, Karussis,D.&Abramsky,O., 1999
Superficial Siderosis of the CNS Associated with Multiple Cavernous Malformations
AJNR 20:1245-1248, Whu,W.C.,et al, 1999
Tracheostomy, In Guillain- Barre Syndrome
Muscle & Nerve 22:1058-1062, Lawn,N.D.&Wijdicks,E.F.M., 1999
Angiitis of the Central Nervous System After Allogeneic Bone Marrow Transplantation?
Stroke 30:1651-1656, Padovan,C.S.,et al, 1999
Recent Advances, Neurology
BMJ 319:362-366, Larner,A.J.&Farmer,S.F., 1999
Subarachnoid Hemorrhage in a Patient with Cerebral Malaria
NEJM 341:611-613, Marx,J.J.,et al, 1999
Prognostic Factors of Guillain-Barre Syndrome After Intravenous Immunoglobulin or Plasma Exchange?
Neurol 53:598-604, Visser,L.H.,et al, 1999
Maternal Thyroid Deficiency During Pregnancy and Subsequent Neuropsychological Development of the Child
NEJM 341:549-555,601, Haddow,J.E.,et al, 1999
Falling Asleep at the Wheel:Motor Vehicle Mishaps in Persons Taking Pramipexole and Ropinirole
Neurol 52:1908-1910, Frucht,S.,et al, 1999
Applications of Diffusion-Perfusion Magnetic Resonance Imaging in Acute Ischemic Stroke
Neurol 52:1750-1756,1733, Fisher,M.&Albers,G.W., 1999
Normal Diffusion-Weighted MRI During Stroke-Like Deficits
Neurol 52:1784-1792,1733, Ay,H.,et al, 1999
Diffusion-Weighted Magnetic Resonance Imaging:Detection of Ischemic Injury 39 Minutes After Onset in a Stroke Patient
Ann Neurol 45:794-797, Yoneda,Y.,et al, 1999
Posterior Cerebral Artery Territory Infarcts in the New England Medical Center Posterior Circulation Registry
Arch Neurol 56:824-832, Yamamoto,Y.,et al, 1999
Low-Dose and High-Dose Acetylsalicylic Acid for Patients Undergoing Carotid Endarterectomy:A Randomised Controlled Trial
Lancet 353:2179-2184,2172, Taylor,D.W.,et al, 1999
Baseline NIH Stroke Scale Score Strongly Predicts Outcome after Stroke, A Report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST)
Neurol 53:126-131, Adams,Jr.,H.P.,et al, 1999
Low-Density Lipoprotein Cholesterol and the Risk of Dementia with Stroke
JAMA 282:254-260, Moroney,J.T.,et al, 1999
Initial Clinical Experience with IV Tissue Plasminogen Activator for Acute Ischemic Stroke:A Multicenter Survey
Neurol 53:424-427, Tanne,D.,et al, 1999